Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03261011

Recruitment Status : Unknown

Verified March 2018 by Akeso ( Akesobio Australia Pty Ltd ).
Recruitment status was: Recruiting

First Posted : August 24, 2017

Last Update Posted : March 9, 2018

Sponsor:

Information provided by (Responsible Party):

Akeso ( Akesobio Australia Pty Ltd )

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	March 2020
Estimated Study Completion Date :	September 2020

To Top